Compare CCCX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCCX | CRMD |
|---|---|---|
| Founded | 2024 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 904.1M | 958.1M |
| IPO Year | 2025 | 2010 |
| Metric | CCCX | CRMD |
|---|---|---|
| Price | $17.08 | $7.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $15.29 |
| AVG Volume (30 Days) | 1.8M | ★ 4.1M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | N/A | ★ $214,303,672.00 |
| Revenue This Year | N/A | $628.67 |
| Revenue Next Year | N/A | $14.64 |
| P/E Ratio | ★ N/A | $3.23 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $10.03 | $5.60 |
| 52 Week High | $27.50 | $17.43 |
| Indicator | CCCX | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 30.29 |
| Support Level | N/A | $6.55 |
| Resistance Level | N/A | $7.59 |
| Average True Range (ATR) | 0.00 | 0.60 |
| MACD | 0.00 | -0.19 |
| Stochastic Oscillator | 0.00 | 12.11 |
Churchill Capital Corp X is a blank check company.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.